Systemic therapy for biliary tract cancer (BTC) has evolved substantially over the past two decades. Gemcitabine plus cisplatin was established as the global standard first-line regimen, followed by further optimization through alternative doublets, intensified triplet chemotherapy, and the recent introduction of immun...
T. Okusaka, J. Furuse, Masaru Konishi et al.· Proceedings of the Japan Aca...· 0 citations
Neuroendocrine carcinoma (NEC) of the biliary tract is an exceptionally rare and highly aggressive malignancy, and its molecular subtype landscape and diagnostic boundaries remain poorly defined. We retrospectively analyzed 42 biliary tract NECs, including 22 surgically resected cases, arising in the intrahepatic bile...
Yumi Asai, Minoru Esaki, Satoshi Nara et al.· American Journal of Surgical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.